Group 1: Company Overview and Market Position - Shandong Boyuan Pharmaceutical Chemical Co., Ltd. specializes in fine chemical research, production, and sales, leveraging a unique business model focused on resource utilization [2][3] - The company has established a diverse product matrix, including organic and inorganic iodides, and luminescent materials, leading in various niche markets [2][3] - Boyuan has participated in the formulation of 3 industry standards and 11 group standards, enhancing its professional influence in the sector [2] Group 2: Circular Economy and Resource Utilization - The company operates a circular economy model centered on the recovery and reuse of iodine and precious metals, significantly reducing raw material dependency and production costs [3][4] - This model not only mitigates risks associated with raw material price fluctuations but also achieves both economic and environmental benefits [3] - The iodine resource utilization business is recognized for its advanced recycling processes and large-scale processing capabilities, maintaining a leading position in the industry [3] Group 3: Innovation and Development Strategy - Boyuan is actively investing in high-tech, high-value new materials and new energy sectors, focusing on technological innovation and industrial upgrades [4][5] - The company is enhancing its R&D capabilities and accelerating the commercialization of research outcomes, aiming for rapid development through innovation [4][5] - Plans include extending the product line into high-value downstream products and exploring new markets, including international expansion [7][8] Group 4: Governance and Investor Relations - The company emphasizes strict management of raised funds, ensuring transparency and alignment with disclosed usage [8] - A stable investor return mechanism is being established to enhance investor confidence and improve corporate governance [8] - Boyuan is committed to green and low-carbon development, optimizing production processes to reduce energy consumption and emissions [9]
博苑股份(301617) - 2025年11月26日投资者关系活动记录表